Aspira Pathlab & Diagnostics Ltd540788Corporate

Healthcare Service Provider Latest results: Jun 2025 7 quarters of data

₹104.32

MCap ₹107 Cr · P/E 44.7

Aspira Pathlab & Diagnostics Ltd — Stock analysis & AI research Aspira Pathlab & Diagnostics Ltd — Live exchange announcements

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹5 Cr

Sales · Jun 2025

+13.1% YoY

₹1 Cr

Operating Profit · Jun 2025

+161.5% YoY

13.0%

OPM % · Jun 2025

+132.1% YoY

₹0 Cr

Net Profit · Jun 2025

+740.0% YoY

₹0.41

EPS · Jun 2025

+720.0% YoY

📝 Aspira Pathlab & Diagnostics Ltd — results explained

Quarter ended June 2025 (Q1 FY26)

Aspira Pathlab & Diagnostics Ltd reported revenue of ₹5 crore for the quarter ended June 2025 (Q1 FY26), up 13.1% from ₹5 crore in the same quarter last year, and down 9.2% sequentially over the March 2025 quarter.

Net profit rose 740.0% year-on-year to ₹0 crore, from ₹0 crore. Earnings per share (EPS) came in at ₹0.41.

Operating profit stood at ₹1 crore — an operating margin (OPM) of 13.0%, compared with 5.6% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY25, Aspira Pathlab & Diagnostics Ltd posted revenue of ₹22 crore, with a net profit of ₹2 crore.

On a trailing-twelve-month (TTM) basis, revenue stands at ₹23 crore with a net profit of ₹2 crore.

Valuation snapshot

At the current price of ₹104.32, 540788 has a market capitalisation of ₹107 crore and a trailing P/E of about 44.7.

Within the Healthcare Service Provider industry, it is the 6th-largest of the 20 companies we track by market value.

Shareholding pattern

As of Mar 2026, promoters held 18.39%, public shareholders 81.61% of Aspira Pathlab & Diagnostics Ltd.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹107 Cr

Current Price ?

₹104.3

P/E ?

44.73above ind

Industry P/E ?

22.50

P/B ?

14.85

P/S ?

4.75

P/FCF ?

64.67

Enterprise Value ?

₹115 Cr

EV/EBITDA ?

33.28

PEG ?

N/A

Earnings Yield ?

1.7%

Dividend Yield ?

0.00%

Profitability & Returns

Sales (TTM) ?

₹23 Cr

OPM ?

15.3%

Profit after tax (TTM) ?

₹2 Cr

EPS (TTM) ?

₹2.33

ROCE ?

17.0%

ROE ?

33.2%

ROA ?

13.7%

Growth

Sales — latest qtr ?

₹5 Cr

PAT — latest qtr ?

₹0 Cr

YoY qtr sales growth ?

13.1%

YoY qtr profit growth ?

740.0%

Sales growth (3y) ?

N/A

Sales growth (5y) ?

N/A

Profit growth (3y) ?

N/A

Profit growth (5y) ?

N/A

Financial Health

Debt ?

₹8 Cr

Debt to Equity ?

1.12

Interest Coverage ?

N/A

Current Ratio ?

N/A

Ownership

Promoter holding ?

18.39%

Change in promoter holding ?

0.00%

Pledged percentage ?

N/A

Market

Return 3 months ?

-14.5%

Return 6 months ?

89.3%

🗓️ Quarterly results (7 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Jun 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	YoY %	QoQ %
Sales	3	4	5	6	5	6	5	+13.1%	-9.2%
Operating Profit	-0	-0	0	1	1	1	1	+161.5%	-26.1%
Other Income	0	0	0	0	0	0	0	-31.2%	-15.4%
Interest	0	0	0	0	0	0	0	—	—
Depreciation	0	0	0	0	0	0	0	-2.6%	+0.0%
Profit Before Tax	-1	-1	0	1	0	1	0	+950.0%	-38.2%
Net Profit	-1	-0	0	1	0	1	0	+740.0%	-38.2%
EPS	-0.70	-0.49	0.05	0.96	0.30	0.66	0.41	+720.0%	-37.9%
OPM %	-16.2%	-5.5%	5.6%	20.6%	11.1%	15.9%	13.0%	+132.1%	-18.2%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	Prev FY	FY25	TTM	YoY %
Sales	—	₹22 Cr	₹23 Cr	—
Operating Profit	—	₹3 Cr	₹3 Cr	—
OPM %	—	13.86%	15.34%	—
NPM %	—	9.22%	10.61%	—
Other Income	—	₹0 Cr	₹0 Cr	—
Depreciation	—	₹2 Cr	₹1 Cr	—
Interest	—	₹0 Cr	₹0 Cr	—
EBIT	—	₹2 Cr	₹2 Cr	—
PBT	—	₹2 Cr	₹2 Cr	—
Tax	—	—	—	—
Net Profit	—	₹2 Cr	₹2 Cr	—
EPS	—	₹1.97	₹2.33	—
Material Cost	—	—	—	—
Employee Cost	—	—	—	—
Extraordinary Items	—	—	—	—

🏛️ Balance Sheet (latest 2 periods)

Metric	Mar 2024	Mar 2025	% Chg
Equity Capital	10.29	10.29	+0.0%
Reserves	-5.08	-3.06	+39.8%
Borrowings	7.71	8.13	+5.4%
Other Liabilities	1.79	2.11	+17.9%
Total Liabilities	14.71	17.47	+18.8%
Fixed Assets	6.79	6.53	-3.8%
CWIP	0.00	0.00	—
Investments	0.00	0.08	—
Other Assets	7.92	10.86	+37.1%
Total Assets	14.71	17.47	+18.8%

💧 Cash Flow (latest 2 periods)

Metric	Mar 2024	Mar 2025	% Chg
Cash from Operating Activity	1.05	1.83	+74.3%
Cash from Investing Activity	0.14	0.12	-14.3%
Cash from Financing Activity	-0.95	-0.99	-4.2%
Net Cash Flow	0.24	0.95	+295.8%
Free Cash Flow	0.79	1.66	+110.1%
CFO/OP	-89%	52%	+158.4%

➗ Ratios (latest 2 periods)

Metric	Mar 2024	Mar 2025	% Chg
Debtor Days	61.94	38.99	-37.1%
Inventory Days	62.69	50.31	-19.7%
Days Payable	101.70	73.00	-28.2%
Cash Conversion Cycle	22.93	16.30	-28.9%
Working Capital Days	25.16	14.10	-44.0%
ROCE %	—	17.04%	—

👥 Shareholding (latest 4 periods)

Metric	Jun 2025	Sep 2025	Dec 2025	Mar 2026	% Chg
Promoters	18.39%	18.39%	18.39%	18.39%	+0.0%
Public	81.62%	81.61%	81.61%	81.61%	+0.0%
No. of Shareholders	1,770	1,755	1,784	1,769	-0.8%

⚖️ Peer comparison

Industry: Healthcare Service Provider · 20 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	NEPHROPLUS Nephrocare Health	₹673.00	6,768	78.9	1,054	85	22.8%	8.1%	—	—	23.6%	33.2%
2	532067 3B BlackBio	₹1,205.90	1,166	18.8	153	56	34.9%	36.7%	47.1%	25.7%	50.7%	-29.0%
3	514330 One Global	₹139.00	1,043	3.7	513	74	19.1%	14.5%	311.6%	288.9%	16.8%	43.0%
4	HEALTHX Health X	₹306.95	976	—	0	-1	-390.4%	-376.2%	—	—	-20.0%	-367.5%
5	526546 Choksi Laboratories	₹61.93	146	19.9	47	2	26.8%	4.6%	10.1%	28.8%	7.5%	49.3%
6	540788 Aspira Pathlab	₹31.00	107	—	26	-0	3.8%	-1.7%	13.5%	-97.1%	17.5%	-108.5%
7	530897 NG Industries	₹165.30	39	28.7	17	2	11.1%	11.4%	-0.9%	-77.7%	13.8%	104.3%
8	524602 Bandaram Pharma	₹30.99	33	162.8	79	1	4.8%	1.5%	70.2%	-46.9%	195.7%	3322.0%
9	524548 Sharma East	₹50.09	32	13.9	37	1	9.6%	3.2%	20.3%	0.0%	13.7%	-18.7%
10	542248 Deccan Health	₹35.53	30	34.8	82	3	6.4%	3.1%	9.1%	115.7%	-0.3%	21.3%
11	539267 Samsrita Labs	₹17.13	28	—	—	—	—	—	—	—	—	—
12	523489 Chennai Meenakshi	₹34.47	28	—	37	-0	1.5%	-1.1%	6.4%	16.1%	-0.7%	100.4%
13	539428 Tejnaksh Healthcare	₹23.46	27	38.5	11	1	26.5%	11.3%	-16.3%	-47.5%	0.5%	24.1%
14	526139 Transgene Biotek	₹9.56	21	—	0	-2	-223.0%	-766.2%	-25.9%	-146.3%	20.0%	9.5%
15	516110 Family Care	₹7.44	11	—	0	-8	-1321.3%	-3505.7%	-97.3%	80.3%	150.0%	39.5%
16	534422 Looks Health	₹5.73	10	177.4	0	0	41.2%	7.5%	-2.6%	0.0%	75.7%	—
17	531043 Dhanvantri Jeevan	₹19.95	10	16.1	28	1	3.2%	1.8%	14.2%	-23.5%	41.6%	200.0%
18	526504 Dolphin Medical	₹1.85	10	5.2	1	0	13.0%	7.4%	-2.6%	333.3%	21.2%	-40.7%
19	541299 Dr Lalchandani	₹27.60	7	345.0	4	0	9.3%	1.7%	—	—	-8.6%	-148.1%
20	526187 Ashram Online.Com	₹6.29	7	—	1	-0	-74.9%	-20.3%	33.3%	-71.4%	31.6%	40.2%

❓ Frequently asked questions

What was Aspira Pathlab & Diagnostics Ltd's revenue in Q1 FY26?

What was Aspira Pathlab & Diagnostics Ltd's net profit in Q1 FY26?